Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | - | 4.0 |
Min SIP Amount | ₹500 | ₹100 |
Expense Ratio | 2.19 | 2.2 |
NAV | ₹13.67 | ₹98.38 |
Fund Started | 17 May 2023 | 25 Mar 1997 |
Fund Size | ₹1499.83 Cr | ₹1072.74 Cr |
Exit Load | Exit Load for units in excess of 10% of the investment,1% will be charged for redemption within 1 year. | Exit load of 1%, if redeemed within 30 days. |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 11.75% | 18.64% |
3 Year | - | 23.05% |
5 Year | - | 23.70% |
1 Year
3 Year
5 Year
Equity | 96.11% | 99.31% |
Cash | -0.35% | 0.69% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
---|---|
HDFC Bank Ltd. | 7.19% |
Infosys Ltd. | 5.88% |
ICICI Bank Ltd. | 5.72% |
Reliance Industries Ltd. | 4.31% |
NTPC Ltd. | 4.12% |
Tata Consultancy Services Ltd. | 3.84% |
Larsen & Toubro Ltd. | 2.92% |
Divi's Laboratories Ltd. | 2.68% |
Coal India Ltd. | 2.64% |
Alkem Laboratories Ltd. | 2.26% |
Name | Assets |
---|---|
HDFC Bank Ltd. | 7.21% |
Infosys Ltd. | 4.57% |
ICICI Bank Ltd. | 4.12% |
Dr. Reddy's Laboratories Ltd. | 3.14% |
State Bank of India | 2.74% |
NTPC Ltd. | 2.64% |
REC Ltd. | 2.49% |
Tech Mahindra Ltd. | 2.23% |
Amber Enterprises India Ltd. | 2.16% |
Suven Pharmaceuticals Ltd. | 2.07% |
Name | Shiv Chanani | Satish Ramanathan |
Start Date | 13 Jul 2022 | 01 Oct 2024 |
Name
Start Date
Description | The scheme seeks to generate long-term capital appreciation from a diversified portfolio of predominantly equity and equity related instruments by following a value investment strategy. | The scheme aims to provide long term capital growth by investing primarily in a well-diversified portfolio of undervalued securities. |
Launch Date | 17 May 2023 | 25 Mar 1997 |
Description
Launch Date